Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Breast Neoplasms/*drug therapy/*pathology"'
Autor:
Catherine Van Poznak, Ryan P. Roop, Timothy J. Pluard, Michael Naughton, Katherine N. Weilbaecher, Farley Johnson, Philip E. Lammers, Jochen G. Schneider, Charles S. Eby
Publikováno v:
Clinical breast cancer, 13(6), 409-15. United States (2013).
BACKGROUND: Blockade of platelet activation and aggregation can inhibit metastasis in preclinical models and is associated with cancer prevention. To test whether disruption of platelet function with clopidogrel and aspirin would decrease the number
Autor:
Ribi, K, Aldridge, J, Phillips, K-A, Thompson, A, Harvey, Vernon, Thürlimann, Beat, Cardoso, Fatima, Pagani, Olivia, Coates, Alan, Goldhirsch, Aron, Price, Karen N., Gelber, R D, Bernhard, Jürg, BIG 1-98 Collaborative and International Breast Cancer Study Groups, International Breast Cancer Study Group
Publikováno v:
British Journal of Cancer, 106 (10
British Journal of Cancer
British Journal of Cancer
In the BIG 1-98 trial objective cognitive function improved in postmenopausal women 1 year after cessation of adjuvant endocrine therapy for breast cancer. This report evaluates changes in subjective cognitive function (SCF).
Journal Article
Journal Article
Autor:
Bruno Vincenzi, Daniele Santini, Alice Zoccoli, Loretta D'Onofrio, Michele Iuliani, Francesco Pantano, Vladimir Virzì, Giuseppe Tonini, Giulia Ribelli, Luciano Stumbo, Chiara Spoto, Marco Fioramonti
Publikováno v:
Breast Cancer Research : BCR
Breast cancer research, 17
Breast cancer research, 17
Bisphosphonates (BPs) are approved as standard therapy in breast cancer for the treatment of bone metastases, since they were demonstrated to reduce the prevalence of skeletal-related events including fractures and hypercalcemia. In the adjuvant sett
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b96a8d4b1095f575987c0b8be071075
http://hdl.handle.net/11573/1641535
http://hdl.handle.net/11573/1641535
Autor:
Fountzilas, George, Papadimitriou, C., Dafni, U., Bafaloukos, Dimitrios, Skarlos, Dimosthenis V., Moulopoulos, L. A., Razi, E. D., Kalofonos, H. P., Aravantinos, Gerasimos, Briassoulis, E. Ch, Papakostas, P., Abela, K., Gogas, H., Kosmidis, Paraskevas A., Pavlidis, Nicholas, Dimopoulos, M. A.
Publikováno v:
Scopus-Elsevier
Journal of Clinical Oncology
Journal of Clinical Oncology
PURPOSE: To compare the efficacy of two different schedules of epirubicin and paclitaxel, as first-line chemotherapy, in patients with advanced breast cancer (ABC). PATIENTS AND METHODS: From October 1997 until May 1999, 183 eligible patients with AB
Publikováno v:
Medical Principles and Practice. 15:153-155
Objective: To report a case of intraocular metastasis from breast carcinoma. Clinical Presentation and Intervention: A 54-year-old woman diagnosed with multifocal ductal adenocarcinoma, grade III, of the left breast presented with blurred vision of t
Publikováno v:
Breast, 18 (4
Comment
Editorial
SCOPUS: ed.j
info:eu-repo/semantics/published
Editorial
SCOPUS: ed.j
info:eu-repo/semantics/published
Autor:
Anna Kalogera-Fountzila, Christos Papadimitriou, Epaminontas Samantas, Dimitris Bafaloukos, E. Briasoulis, Maria Karina, Urania Dafni, Nikos Maniadakis, George Fountzilas, H. P. Kalofonos, Meletios A. Dimopoulos, Angelos Koutras, Gerassimos Aravantinos, P. Kosmidis, D.V. Skarlos, D.G. Pectasides, F. Matsiakou, Helen Gogas, Pavlos Papakostas, C. Christodoulou
BACKGROUND: Effective anthracycline-free combinations need to be evaluated in metastatic breast cancer (MBC), due to the increased number of patients treated with anthracycline-based adjuvant chemotherapy. PATIENTS AND METHODS: Patients with MBC were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93c2a1a83506f42d7629b1fc0a96f5a1
http://olympias.lib.uoi.gr/jspui/handle/123456789/24248
http://olympias.lib.uoi.gr/jspui/handle/123456789/24248